Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof

US10078088B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10078088-B2
Application numberUS-201715816505-A
CountryUS
Kind codeB2
Filing dateNov 17, 2017
Priority dateJul 16, 2010
Publication dateSep 18, 2018
Grant dateSep 18, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the field of GPCR structure biology and signaling. In particular, the present invention relates to protein binding domains directed against or capable of specifically binding to a functional conformational state of a G-protein-coupled receptor (GPCR). More specifically, the present invention provides protein binding domains that are capable of increasing the stability of a functional conformational state of a GPCR, in particular, increasing the stability of a GPCR in its active conformational state. The protein binding domains of the present invention can be used as a tool for the structural and functional characterization of G-protein-coupled receptors bound to various natural and synthetic ligands, as well as for screening and drug discovery efforts targeting GPCRs. Moreover, the invention also encompasses the diagnostic, prognostic and therapeutic usefulness of these protein binding domains for GPCR-related diseases.

First claim

Opening claim text (preview).

What is claimed is: 1. A polypeptide comprising an amino acid sequence that consists of 4 framework regions (FR1 to FR4, respectively) and 3 complementary determining regions (CDR1 to CDR3, respectively) according to the formula: FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4, wherein CDR1 is the amino acid sequence of SEQ ID NO:30 or an amino acid sequence that has at least 80% identity with SEQ ID NO:30, wherein CDR2 is the amino acid sequence of SEQ ID NO:43 or an amino acid sequence that has at least 80% identity with SEQ ID NO:43, wherein CDR3 is the amino acid sequence of SEQ ID NO:57 or an amino acid sequence that has at least 80% identity with SEQ ID NO:57, and wherein the polypeptide has binding activity for a β2AR. 2. The polypeptide according to claim 1 comprising an amino acid sequence that has at least 80% identity with an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 and SEQ ID NO:5. 3. A composition comprising the polypeptide according to claim 1 . 4. A composition comprising the polypeptide according to claim 2 .

Assignees

Inventors

Classifications

  • Drugs for disorders of the cardiovascular system · CPC title

  • Immunosuppressants, e.g. drugs for graft rejection · CPC title

  • Antineoplastic agents · CPC title

  • Antibacterial agents · CPC title

  • Drugs for disorders of the nervous system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10078088B2 cover?
The present invention relates to the field of GPCR structure biology and signaling. In particular, the present invention relates to protein binding domains directed against or capable of specifically binding to a functional conformational state of a G-protein-coupled receptor (GPCR). More specifically, the present invention provides protein binding domains that are capable of increasing the sta…
Who is the assignee on this patent?
Vib Vzw, Univ Brussel Vrije, Univ Leland Stanford Junior
What technology area does this patent fall under?
Primary CPC classification C07K14/705. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).